(Q42513827)

1 November 2017

title

Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen (English)

1 reference

1 November 2017

0 references

Sunhyo Jeong

1

1 reference

1 November 2017

Michung Yoon

series ordinal

2

1 reference

1 November 2017

publication date

1 June 2007

1 reference

1 November 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Obesity

1 reference

1 November 2017

volume

15

1 reference

1 November 2017

issue

6

1 reference

1 November 2017

page(s)

1430-1440

1 reference

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Orphan nuclear receptors: shifting endocrinology into reverse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Roles of PPARs in health and disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Analysis of peroxisome proliferator-responsive enhancer of the rat acyl-CoA oxidase gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

The peroxisome proliferator response element (PPRE) present at positions -681/-669 in the rat liver 3-ketoacyl-CoA thiolase B gene functionally interacts differently with PPARalpha and HNF-4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Dietary-induced obesity: effect of dietary fats on adipose tissue cellularity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Gonadal steroids and energy homeostasis in the leptin era.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Replacement estrogen use and body mass index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Estradiol increases glucagon's satiating potency in ovariectomized rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Estrogen effects on triglyceride metabolism in analbuminemic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Effects of physical training on body composition and organ weights in ovariectomized and hyperestrogenic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Modulation of appetite by gonadal steroid hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Beta-very low density lipoprotein induces triglyceride accumulation through receptor mediated endocytotic pathway in 3T3-L1 adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

Independent effects of estradiol on water and food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.171

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2007.171

1 reference

1 November 2017

1 reference